LMA I-Gel Versus LMA Protector During Minor Urological Procedures Under General Anesthesia in Adult Patients

Last updated: April 2, 2025
Sponsor: Nikolopoulou Maria Zozefin
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anesthesia

Treatment

LMA protector

LMA igel

Clinical Study ID

NCT06825910
19242/29.08.24
  • Ages 18-90
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This will be a randomized comparative study comparing the two supraglottic devices i-gel and Protector, intraoperatively, during minor urological procedures under general anesthesia in adult patient.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ASA I-II

  • Patients older than 18 years

  • Procedures in supine and lithotomy position

Exclusion

Exclusion Criteria:

  • Tumors or anatomical anomalies of the upper airway

  • Known history of difficult intubation

  • Limited mouth opening less than 2cm

  • Decreased compliance of the lungs or the thoracic cage

  • Need of mechanical ventilation after the surgery

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: LMA protector
Phase:
Study Start date:
March 13, 2025
Estimated Completion Date:
July 30, 2025

Study Description

This randomized comparative study aims to evaluate the effectiveness, safety, and unwanted effects of two laryngeal mask airway devices, the iGel and the Protector. The study will involve adult patients during minor urological procedures under general anesthesia. Participants will be divided into two groups: in one group will be inserted the iGel laryngeal mask airway, while in the other group will be inserted the Protector laryngeal mask airway.

Connect with a study center

  • SismanoglioGH

    Athens,
    Greece

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.